Total Recomposition uses Tesamorelin—a GHRH analog that preferentially reduces visceral abdominal fat—combined with Ipamorelin, a selective GH secretagogue that supports lean mass, recovery, and performance. Delivered as a cyclical, non‑FDA–approved protocol with informed consent, the program layers nightly or near‑nightly injections, labs (including IGF‑1), and a tailored training and nutrition plan.

Tesamorelin binds to GHRH receptors in the anterior pituitary, increasing pulsatile growth hormone and downstream IGF‑1, which selectively stimulates lipolysis in visceral adipose tissue while largely preserving subcutaneous fat and lean muscle. Clinical data show significant visceral fat (VAT) reduction and improved fat “quality” and lipids in studied populations. Ipamorelin activates the ghrelin/GHS‑R pathway to trigger physiologic GH release with minimal impact on other pituitary hormones, supporting protein synthesis, lean mass, recovery, and metabolic rate. Together, the stack promotes a recomposition effect: less deep belly fat, better muscle tone, and improved metabolic markers under medical supervision.
Our Tesamorelin + Ipamorelin peptide blendis designed to target:
Tesamorelin + Ipamorelin is believed to help with:
Experience the best in aesthetic and wellness care at Better Med Spa. Our personalized treatments are tailored to you, designed to help you look and feel your absolute best with confidence and ease.
We're here to answer your questions and provide the best services for your needs.
Total Recomposition focuses on where and what you lose—visceral fat while preserving or enhancing lean muscle—rather than just driving the scale down. GLP‑1 programs are excellent for appetite and weight reduction; Tesamorelin + Ipamorelin is ideal for clients who want a more athletic, defined body composition and are willing to train and eat accordingly.
Tesamorelin is FDA‑approved for HIV‑associated lipodystrophy, but this combination and its use for general body recomposition are off‑label and non‑FDA–approved. Total Recomposition is offered only under a non‑FDA–approved informed consent model that explains the research, regulatory status, and alternatives.
Most clients first notice changes in sleep, recovery, and training capacity within 2–3 weeks; visible shifts in midsection fat and muscle definition commonly appear over 6–12 weeks when combined with strength training and nutrition changes. Better Med Spa encourages DEXA or body‑comp scans, photos, and tape measurements to track recomposition rather than scale alone.
Potential effects include injection‑site irritation, fluid retention, joint aches, tingling, changes in blood sugar or lipids, and shifts in IGF‑1; rare but serious concerns include neoplasia risk, carpal tunnel–like symptoms, or glucose intolerance. Because long‑term safety data—especially for off‑label use—are limited, Better Med Spa screens thoroughly, avoids use in clients with active malignancy or uncontrolled metabolic disease, and monitors labs regularly.
Total Recomposition pairs naturally with GLP‑1 weight‑loss programs, body‑contouring, IV performance drips, and K‑Beauty facials, so clients see and feel change from every angle. Operationally, it works best inside “Performance & Recomp” memberships that bundle peptides, training guidance, body‑comp scans, and aesthetic services, with automated follow‑ups to track waist, strength, energy, and satisfaction—driving both outcomes and recurring revenue.